Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 6,053 | 5,065 | 3,894 | 0 |
| Operating Income | -6,053 | -5,065 | -3,894 | N/A |
| Other Income | -15 | 7,322 | 67 | 0 |
| Pre-tax Income | -6,068 | 2,257 | -3,827 | 0 |
| Net Income Continuous | -6,068 | 2,257 | -3,827 | N/A |
| Net Income | $-6,068 | $2,257 | $-3,827 | $N/A |
| EPS Basic Total Ops | -6.61 | 2.35 | -4.58 | N/A |
| EPS Basic Continuous Ops | -6.61 | 2.38 | -4.58 | N/A |
| EPS Diluted Total Ops | -6.61 | 0.22 | -4.58 | N/A |
| EPS Diluted Continuous Ops | -6.61 | 0.22 | -4.58 | N/A |
| EBITDA(a) | $-6,012 | $-5,023 | $-3,871 | $N/A |